Home > Library > AYA fintech network platform: major milestones, key product features, and online social network services
Author Chanel Holden
Our fintech finbuzz analytic report shines light on the current global macro-financial outlook. As of Summer-Fall 2023, this report focuses on the major milestones, key product features, and online social media services across our AYA fintech network platform. The AYA major milestones include our proprietary alpha stock investment model configuration, U.S. fintech patent protection and accreditation for 20 years, landmark ebook publications on the Trump to Biden economic policy reforms, and new empirical research articles on macrofinance, asset return prediction, financial intermediary capital structure, and corporate ownership governance. We include a complete fintech founder profile toward the end of this report.
Description:
Our fintech finbuzz analytic report shines light on the current global macro-financial outlook. As of Summer-Fall 2023, this report focuses on the major milestones, key product features, and online social media services across our AYA fintech network platform. The AYA major milestones include our proprietary alpha stock investment model configuration, U.S. fintech patent protection and accreditation for 20 years, landmark ebook publications on the Trump to Biden economic policy reforms, and new empirical research articles on macrofinance, asset return prediction, financial intermediary capital structure, and corporate ownership governance. We include a complete fintech founder profile toward the end of this report.
This analytic report cannot constitute any form of financial advice, analyst opinion, recommendation, or endorsement. We refrain from engaging in financial advisory services, and we seek to offer our analytic insights into the latest economic trends, stock market topics, investment memes, and other financial issues. Our proprietary alpha investment algorithmic system helps enrich our AYA fintech network platform as a new social community for stock market investors: https://ayafintech.network.
We share and circulate these informative posts and essays with hyperlinks through our blogs, podcasts, emails, social media channels, and patent specifications. Our goal is to help promote better financial literacy, inclusion, and freedom of the global general public. While we make a conscious effort to optimize our global reach, this optimization retains our current focus on the American stock market.
This free ebook, AYA Analytica, shares new economic insights, investment memes, and stock portfolio strategies through both blog posts and patent specifications on our AYA fintech network platform. AYA fintech network platform is every investor’s social toolkit for profitable investment management. We can help empower stock market investors through technology, education, and social integration.
We hope you enjoy the substantive content of this ebook! AYA!
Andy Yeh
Chief Financial Architect (CFA) and Financial Risk Manager (FRM)
Brass Ring International Density Enterprise (BRIDE) ©
2018-04-20 10:38:00 Friday ET
Allianz chairman Mohamed El-Erian bolsters a new American economic paradigm in lieu of the Washington consensus. The latter dominates the old school of thou
2019-08-14 10:31:00 Wednesday ET
Netflix suffers its first major loss of U.S. subscribers due to the recent price hikes. The company adds only 2.7 million new subscribers in 2019Q2 in stark
2019-08-05 13:30:00 Monday ET
China continues to sell U.S. Treasury bonds amid Sino-U.S. trade truce uncertainty. In mid-2019, China reduces its U.S. Treasury bond positions by $20.5 bil
2018-05-11 09:37:00 Friday ET
OPEC countries have cut the global glut of oil production in recent years while the resultant oil price has surged from $30 to $78 per barrel from 2015 to 2
2023-01-11 09:26:00 Wednesday ET
Addendum on USPTO fintech patent protection and accreditation As of early-January 2023, the U.S. Patent and Trademark Office (USPTO) has approved our U.S
2019-01-10 17:31:00 Thursday ET
The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be
